電子アスピリンの世界市場 - 市場規模：疼痛タイプ別、エンドユーザー別、地域別、予測

電子アスピリンの市場規模と予測

電子アスピリン市場規模は、2024年に46億7,000万米ドルと評価され、2026年から2032年の予測期間中にCAGR 5.89％で成長し、2032年までに63億3,000万米ドルに達すると予測されます。

市場成長を促進する主な要因としては、技術の進歩、継続的な顔面頭痛、群発頭痛、片頭痛などの症状に悩む人々の増加などが挙げられます。さらに、ライフスタイルの変化や仕事に関連したストレスは、これらの症状の事例を増加させている他の要因の一部であり、予測期間中の市場の成長にプラスに寄与すると期待されています。電子アスピリンの世界市場レポートは、市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

電子アスピリンの世界市場定義

電子アスピリンは、Automatic Technologies社が開発した医療機器であり、片頭痛、頭痛、緊張型頭痛などの症状の痛みを緩和するのに役立ちます。電子アスピリンは神経を模擬したインプラントで、歯肉上部の骨腔の奥深くにある神経の集合体である蝶形口蓋神経節（SPG）に接続されます。この装置は、低侵襲手術によって埋め込まれ、ハンドヘルド装置で制御されます。装置は低レベルの電子インパルスを送り、神経終末を刺激して痛みの受容体をブロックするのに役立ちます。

片頭痛のような症状に対する意識の高まり、技術の進歩、製品認可の増加は、予測期間中の市場成長に寄与すると予想される主な要因の一部です。さらに、神経疾患の世界の有病率の増加や、認知度向上のための政府イニシアチブの増加は、市場の成長にさらに貢献すると予想されます。

電子アスピリンの世界市場概要

片頭痛（通常、脳の片側に脈打つ感覚やズキズキする痛みを引き起こす頭痛）の有病率の増加は、この装置が使用される主要な症状です。片頭痛は通常、嘔吐、吐き気、音や光に対する極度の過敏症を伴います。片頭痛の予防治療には通常、薬物、注射、皮膚パッチ、点鼻薬などが用いられ、発症後に症状を止めるのに役立ちます。この疾患の有病率の高さは、市場の成長を支えるものと期待されています。例えば、国立医学図書館の記事によると、片頭痛は最も一般的な神経疾患の一つであり、世界で10億人以上が罹患しています。この疾患は若年成人や女性に多く見られます。

さらに、頭痛や仕事に関連したストレスの増加が、この装置の需要を支えていると予想されています。世界保健機関（WHO）によると、成人の頭痛有病率は50％です。さらに、18～65歳の半数から4分の3が頭痛に悩まされています。このうち30％が片頭痛に悩まされていると報告されています。頭痛は一般的な現象であるため、ほとんどの人は鎮痛薬として知られるアスピリンを含む自己治療薬に頼っています。

目次

第1章 電子アスピリンの世界市場のイントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 電子アスピリンの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 電子アスピリンの世界市場：疼痛タイプ別

• 概要
• 片頭痛
• 群発性頭痛
• 頭痛・顔面痛

第6章 電子アスピリンの世界市場：エンドユーザー別

• 概要
• 病院
• クリニック
• 外来手術センター

第7章 電子アスピリンの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • その他のラテンアメリカ
• 中東・アフリカ
  • アラブ首長国連邦
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第8章 電子アスピリンの世界市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第9章 企業プロファイル

• Autonomic Technologies, Inc.
  • 概要
  • 業績
  • 製品展望
  • 主な発展

第10章 主な発展

• 製品の上市／開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第11章 付録

• 関連調査

Electronic Aspirin Market Size And Forecast

Electronic Aspirin Market size was valued at USD 4.67 Billion in 2024 and is projected to reach USD 6.33 Billion by 2032, growing at a CAGR of 5.89% during the forecast period 2026-2032.

Major factors which drive the market growth include advances in technology, and a growing number of people suffering from conditions such as ongoing facial headaches, cluster headaches, and migraine. Moreover, changing lifestyles and work-related stress are some of the other factors that are increasing the instances of these conditions, which is expected to positively contribute to the growth of the market during the forecast period. The Global Electronic Aspirin Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Electronic Aspirin Market Definition

Electronic Aspirin is a medical device developed by Automatic Technologies that helps to alleviate pain from conditions such as migraines, headaches, and tension headaches. Electronic aspirin is a nerve-simulated implant that is connected to the Sphenopalatine Ganglion (SPG) which is a collection of nerves deep in the bone cavity of the upper gum. The device is implanted through a minimally invasive procedure and is controlled through a handheld device. The device sends low-level electronic impulses that stimulate the nerve endings that help to block the pain receptors.

Growing awareness about conditions such as migraines, technological advancement, and increasing product approvals are some of the key factors which are expected to contribute to the growth of the market during the forecast period. Moreover, the increasing prevalence of neurological conditions globally and increasing government initiatives in order to improve awareness are expected to further contribute to the growth of the market.

Global Electronic Aspirin Market Overview

The increasing prevalence of migraine a headache that causes pulsating sensation or throbbing pain usually on one side of the brain is a key condition for which the device is used. Migraine is usually accompanied by vomiting, nausea, and extreme sensitivity to sound and light. Preventive treatment for the condition usually involves drugs, injections, skin patches, and nasal sprays that help to stop the condition after its onset. The high prevalence of the condition is expected to support the growth of the market. For instance, according to an article by the National Library of Medicine, Migraine is one of the most common neurological disorders that affects more than 1 billion people globally. The condition is most common in young adults and females.

Moreover, increasing instances of headaches and work-related stress are expected to support the demand for the devices. According to the World Health Organization, the prevalence of headaches among adults was 50%. Moreover, half or three-quarters between the age of 18-65 suffer from headaches. Among this population, 30% of these individuals are reported to suffer from migraine. Due to headaches being a common phenomenon most people resort to self-medication which includes Aspirin which is a well-known analgesic.

Global Electronic Aspirin Market Segmentation Analysis

The Global Electronic Aspirin Market is segmented based on Pain Type, End-User, And Geography.

Electronic Aspirin Market, By Pain Type

• Migraines
• Cluster Headaches
• Head and Facial Pain

Based on the Pain Type, The market is bifurcated into Migraines, Cluster Headaches, and Head and Facial Pain. The cluster headaches segment is expected to dominate during the forecast period owing to the higher prevalence of the condition among the population due to changing lifestyles and increasing work-related stress. For instance, according to an article by the American Institute of Stress, more than 40% of workers have reported job stress.

Electronic Aspirin Market, By End-User

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Based on End-User, The market is bifurcated into Hospitals, Clinics, and Ambulatory Surgical Centers. The hospital segment held the largest share in 2022 due to the higher number of people undergoing treatment for conditions at the hospitals. Moreover, the availability of advanced infrastructure and favorable reimbursement policies are expected to support the growth of the segment during the forecast period.

Electronic Aspirin Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, The Global Electronic Aspirin Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest market in the global Electronic Aspirin Market this is attributed to the growing prevalence of neurological conditions, headaches, and migraines among the populations in the region. Moreover changing lifestyle and increasing work-related stress among young adults and adults is expected to positively impact the growth of the market.

Key Players

The "Global Electronic Aspirin Market" study report will provide valuable insight with an emphasis on the global market. Autonomic Technologies, Inc. Cefaly Technology, Omron Healthcare, TheraGun, Cochlear Limited, and Neurostim are the sole companies operating in the market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• In December 2022, Unity HA acquired the Intellectual Property of Autonomic Technologies. The acquisition will help Unity HA to continue with its new goal to continue advance cost-effective technologies in order to prevent and treat cluster headaches.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
• Market Attractiveness
• The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Electronic Aspirin Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Electronic Aspirin Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ELECTRONIC ASPIRIN MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ELECTRONIC ASPIRIN MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ELECTRONIC ASPIRIN MARKET, BY PAIN TYPE

• 5.1 Overview
• 5.2 Migraines
• 5.3 Cluster Headaches
• 5.4 Head and Facial Pain

6 GLOBAL ELECTRONIC ASPIRIN MARKET, BY END-USER

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Clinics
• 6.4 Ambulatory Surgical Centers

7 7GLOBAL ELECTRONIC ASPIRIN MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 The U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 The U.K.
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
  • 7.5.3 Rest of LATAM
• 7.6 Middle East and Africa
  • 7.6.1 UAE
  • 7.6.2 Saudi Arabia
  • 7.6.3 South Africa
  • 7.6.4 Rest of the Middle East and Africa

8 GLOBAL ELECTRONIC ASPIRIN MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILE

• 9.1 Autonomic Technologies, Inc.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research